Skip to main content

Cabaletta Bio, Inc.

CABA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001759138

No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Cabaletta Bio, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CABA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6361−2
Shares15.8M17.4M+1.62M (+10.3%)
Value$135.5M$211.3M+$75.8M (+56.0%)

New holders (10)

Institutions that held Cabaletta Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CABA in Q3 2021
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.900,000$10.9M0.05%
Samlyn Capital, LLC349,475$4.25M0.06%
Acuta Capital Partners, LLC302,926$3.68M1.31%
OrbiMed Advisors LLC302,509$3.68M0.04%
Fred Alger Management, LLC214,721$2.61M0.01%
Ghost Tree Capital, LLC100,000$1.22M0.40%
Marshall Wace, LLP64,155$780.0K0.00%
Silverarc Capital Management, LLC42,022$511.0K0.30%
Susquehanna Fundamental Investments, LLC12,324$150.0K0.00%
Group One Trading, L.P.200$2.00K0.00%

Sold out (12)

Institutions that held Cabaletta Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of CABA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Tibra Equities Europe Ltd45,900$395.0K
First Trust Advisors LP35,952$309.0K
FMR LLC35,650$307.0K
ExodusPoint Capital Management, LP33,857$291.0K
Gsa Capital Partners LLP33,753$290.0K
Jane Street Group, LLC16,366$141.0K
Renaissance Technologies LLC14,900$128.0K
Alpine Global Management, LLC14,072$121.0K
Royal Bank of Canada1,476$13.0K
New York State Common Retirement Fund102$1.00K
Federated Hermes, Inc.126$1.00K
TCI Wealth Advisors, Inc.50$0